290 related articles for article (PubMed ID: 22004990)
21. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
22. Non-AIDS-defining cancers among HIV-infected people.
Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
[TBL] [Abstract][Full Text] [Related]
23. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
24. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
25. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
[TBL] [Abstract][Full Text] [Related]
26. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YM; Merati T; Zhang F; Lim PL; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich A; Law MG;
J Int AIDS Soc; 2010 Dec; 13():51. PubMed ID: 21143940
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus and cancer. A population of HIV-infected patients at Hospital de Santa Maria and predictors of cancer.
Sofia Fernandes L
Germs; 2012 Jun; 2(2):60-74. PubMed ID: 24432264
[TBL] [Abstract][Full Text] [Related]
28. Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.
Rees CA; Keating EM; Lukolyo H; Danysh HE; Scheurer ME; Mehta PS; Lubega J; Slone JS;
Pediatr Blood Cancer; 2016 Aug; 63(8):1325-31. PubMed ID: 27082516
[TBL] [Abstract][Full Text] [Related]
29. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
30. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
31. Are Non-HIV Malignancies Increased in the HIV-Infected Population?
Thrift AP; Chiao EY
Curr Infect Dis Rep; 2018 May; 20(8):22. PubMed ID: 29804238
[TBL] [Abstract][Full Text] [Related]
32. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
[TBL] [Abstract][Full Text] [Related]
33. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
34. Malignancies in HIV-Infected and AIDS Patients.
Ji Y; Lu H
Adv Exp Med Biol; 2017; 1018():167-179. PubMed ID: 29052137
[TBL] [Abstract][Full Text] [Related]
35. HIV infection and the risk of cancers with and without a known infectious cause.
Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
[TBL] [Abstract][Full Text] [Related]
36. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
37. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
38. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
[TBL] [Abstract][Full Text] [Related]
39. One world, one hope: the cost of providing antiretroviral therapy to all nations.
Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
